|20.05.2021||17.00 - 17.55 h|
|27.05.2021||17.00 - 17.55 h|
|03.06.2021||17.00 - 17.55 h|
|10.06.2021||17.00 - 17.55 h|
|17.06.2021||17.00 - 17.55 h|
Dear colleagues and dear friends
Traditionally, a course of radiotherapy extended over several weeks. Technological advances combined with a better understanding of radiobiology have allowed a fundamental change of radiotherapy: treatment with a substantially reduced number of highly-focused fractions is today becoming an option for selected patients or even a standard of care.
This virtual “5×5” symposium summarized the current evidence on radiation therapy for breast, lung, pancreatic, prostate and rectal cancer in a maximum of five fractions. International experts explained the reasons for the extreme hypofractionation, the available evidence for or against 5-fraction radiation therapy and the relevance for interdisciplinary cancer care.
The virtual symposium was divided into 5 weekly sessions of 55 minutes each. Each session focused on one tumor entity and each session could be attended separately.
May 20th 2021, 17.00 – 17.55 h
5 Fraction Radiotherapy in Rectal Cancer
Keynote Lecture: Cancer Claus Rödel, Prof. Dr., University Hospital Frankfurt, GER
May 27th 2021, 17.00 – 17.55 h
5 Fraction Radiotherapy in Breast Cancer
Keynote Lecture: Murray Brunt, Prof. Dr., Keele University, School of Medicine, UK
June 3rd 2021, 17.00 – 17.55 h
5 Fraction Radiotherapy in Prostate Cancer
Keynote Lecture: Nicholas van As, Dr., Royal Marsden Hospital London, Institute of Cancer Research, UK
June 10th 2021, 17.00 – 17.55 h
5 Fraction Radiotherapy in Pancreatic Cancer
Keynote Lecture: Maria Hawkins, Prof. Dr., University College London, UK
June 17th 2021, 17.00 – 17.55 h
5 Fraction Radiotherapy in Lung Cancer
Keynote Lecture: Suresh Senan, Prof. Dr., Amsterdam University Medical Centers, The Netherlands